TY  - CHAP
M1  - Book, Section
TI  - Evaluation of Patients with Suspected Coronary Artery Disease Using Nuclear Myocardial Perfusion Imaging
A1  - Nair, Sanjeev U.
A1  - Heller, Gary V.
A2  - Heller, Gary V.
A2  - Hendel, Robert C.
Y1  - 2017
N1  - 
T2  - Nuclear Cardiology: Practical Applications, 3e
AB  - The  worldwide  burden  of  coronary  artery  disease  (CAD)  remains  substantial.  Annually,  an  estimated  1.5%  of  the  US  population  visits  the  primary  care  services  with  symptoms  of  chest  pain.1  Each  year  over  660,000  patients  in  the  United  States  present  to  hospital  with  either  a  first  myocardial  infarction  (MI)  or  sudden  cardiac  death  (SCD)  due  to  CAD.2  Of  these  305,000  will  have  had  a  recurrent  MI.  An  estimated  160,000  will  also  suffer  a  silent  first  MI.2  CAD  is  the  leading  cause  of  death  across  the  world  and  is  predicted  to  remain  so  for  the  next  20  years.  Annually,  approximately  3.8  million  men  and  3.4  million  women  die  from  CAD.  The  number  is  estimated  to  rise  to  11.1  million  deaths  globally  by  2020.3  An  estimated  $108.9  billion  is  spent  annually  on  treatment  of  CAD  and  is  expected  to  exceed  $320  billion  by  the  year  2030.2  Thus,  means  and  methods  to  reduce  the  prevalence,  morbidity,  and  mortality  associated  with  CAD  remain  of  great  importance  to  health  care  providers.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesscardiology.mhmedical.com/content.aspx?aid=1145444030
ER  -